Journal article discussing the concept that all areas where the worm that causes onchocerciasis might currently be transmitted—and where mass drug administration (MDA) with ivermectin treatment has not been delivered previously—must now be identified by careful, detailed “elimination mapping”.
The purpose of this publication is to provide proof of concept that, through a strong partnership between Merck’s donation of Mectizan, the endemic countries and donors, we can eliminate onchocerciasis, a scourge that was once classified as a disease that could only be controlled.
This article addresses elimination of onchocerciasis transmission in the Americas. With four of the six originally endemic American countries now WHO verified as having eliminated onchocerciasis transmission, and 95% of ivermectin treatments in the region halted, the regional focus is now on the remaining active transmission zone, called the Yanomami Area, on the border between Venezuela and Brazil.
Article covering the role national onchocerciasis elimination committees (NOECs) play in helping ministries of health complete the pathway to successful verification of elimination of onchocerciasis (river blindness), as outlined in the 2016 World Health Organization guidelines.
This article covers the role of the NGDO Coordination Group for the Control of Onchocerciasis. The Group was launched in 1992, and with the paradigm shift from control of disease to elimination of onchocerciasis transmission, the Group shifted its orientation to that new paradigm in 2013.
In this article, the author explains “…the dire consequences of many untreated NTDs are chronic disease and disability. Thus, they contribute significantly to the global burden of chronic conditions and their consequences such as stigma, exclusion and poverty.”
Five years after the policy change from river blindness control to elimination, the Ministry of Health would like to announce the interruption of transmission in the Metema river blindness focus in Amhara Regional State.
At the African Union summit in January 2018, Uniting to Combat NTDs presented African leaders with a new NTD index and bespoke country profiles for African countries to show progress against the five NTDs amenable to preventive chemotherapy.
In his speech, Professor Hawking highlighted the work and legacy of his father, Dr Frank Hawking who, in the 1950s, was one of the first people to conduct research into and develop treatment for an NTD known as lymphatic filariasis (LF).
The Survey Sample Builder is a tool designed to help program managers with their Transmission Assessment Surveys. The SSB program can be used to automate the calculations for determining appropriate survey strategy.